JP2001515060A5 - - Google Patents

Download PDF

Info

Publication number
JP2001515060A5
JP2001515060A5 JP2000509683A JP2000509683A JP2001515060A5 JP 2001515060 A5 JP2001515060 A5 JP 2001515060A5 JP 2000509683 A JP2000509683 A JP 2000509683A JP 2000509683 A JP2000509683 A JP 2000509683A JP 2001515060 A5 JP2001515060 A5 JP 2001515060A5
Authority
JP
Japan
Prior art keywords
dna
embedded image
lipid
lipids
liposome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000509683A
Other languages
English (en)
Japanese (ja)
Other versions
JP4504559B2 (ja
JP2001515060A (ja
Filing date
Publication date
Priority claimed from DE19834683A external-priority patent/DE19834683A1/de
Application filed filed Critical
Priority claimed from PCT/EP1998/005156 external-priority patent/WO1999008997A1/de
Publication of JP2001515060A publication Critical patent/JP2001515060A/ja
Publication of JP2001515060A5 publication Critical patent/JP2001515060A5/ja
Application granted granted Critical
Publication of JP4504559B2 publication Critical patent/JP4504559B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000509683A 1997-08-13 1998-08-13 新リポポリアミン、その調製および適用 Expired - Fee Related JP4504559B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19735125 1997-08-13
DE19834683A DE19834683A1 (de) 1997-08-13 1998-07-31 Neue Lipopolyamine, deren Darstellung und Anwendung
DE19834683.2 1998-07-31
DE19735125.5 1998-07-31
PCT/EP1998/005156 WO1999008997A1 (de) 1997-08-13 1998-08-13 Neue lipopolyamine, deren darstellung und anwendung

Publications (3)

Publication Number Publication Date
JP2001515060A JP2001515060A (ja) 2001-09-18
JP2001515060A5 true JP2001515060A5 (https=) 2010-05-06
JP4504559B2 JP4504559B2 (ja) 2010-07-14

Family

ID=26039111

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000509683A Expired - Fee Related JP4504559B2 (ja) 1997-08-13 1998-08-13 新リポポリアミン、その調製および適用

Country Status (8)

Country Link
US (1) US6281371B1 (https=)
EP (1) EP1003711B1 (https=)
JP (1) JP4504559B2 (https=)
AT (1) ATE208369T1 (https=)
AU (1) AU745958B2 (https=)
CA (1) CA2299429C (https=)
ES (1) ES2167939T3 (https=)
WO (1) WO1999008997A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999052858A2 (en) * 1998-04-08 1999-10-21 Celltech Therapeutics Limited Lipids
US6852334B1 (en) * 1999-04-20 2005-02-08 The University Of British Columbia Cationic peg-lipids and methods of use
WO2000064858A1 (en) * 1999-04-26 2000-11-02 Celltech R&D Limited Bipolar lipids and their use for the delivery of bioactive substances
WO2001043778A1 (en) * 1999-12-17 2001-06-21 Gene Therapy Systems, Inc. Use of cationic lipids for intracellular protein delivery
US7189705B2 (en) 2000-04-20 2007-03-13 The University Of British Columbia Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers
US7294511B2 (en) * 2001-03-22 2007-11-13 Chromos Molecular Systems, Inc. Methods for delivering nucleic acid molecules into cells and assessment thereof
US7001925B1 (en) 2002-09-27 2006-02-21 University Of Central Florida Research Foundation, Inc. Compounds and method for enhancing the efficacy of anti-cancer drugs
US7906122B2 (en) * 2003-06-18 2011-03-15 Yissum Research Development Company Of The Hebrew University Of Jersusalem Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination
EP1638919B1 (en) * 2003-06-18 2012-09-26 Biolab Ltd. Sphingolipids polyalkylamines conjugates
US20110045001A1 (en) * 2008-03-28 2011-02-24 Biontex Laboratories Gmbh Transfection results of non-viral gene delivery systems by influencing of the innate immune system
WO2013016058A1 (en) * 2011-07-22 2013-01-31 Merck Sharp & Dohme Corp. Novel bis-nitrogen containing cationic lipids for oligonucleotide delivery
WO2016075154A1 (en) 2014-11-10 2016-05-19 Ethris Gmbh Induction of osteogenesis by delivering bmp encoding rna
HUE065017T2 (hu) 2019-02-14 2024-04-28 Ethris Gmbh Poliribonukleotid ciliogenezisre gyakorolt hatásának elemzése
WO2022096582A1 (en) 2020-11-04 2022-05-12 Ethris Gmbh Use of ifn-lambda mrna for treating viral infections
WO2024121160A1 (en) 2022-12-05 2024-06-13 Ethris Gmbh Regulator(s) of energy homeostasis-encoding rna molecule(s) with increased translation efficiency

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963189A1 (de) 1969-12-17 1971-06-24 Bayer Ag Verfahren zur Herstellung von flammfesten,Urethangruppen aufweisenden Schaumstoffen
US4339767A (en) 1980-05-05 1982-07-13 International Business Machines Corporation High performance PNP and NPN transistor structure
CA2489769A1 (en) 1989-03-21 1990-10-04 Philip L. Felgner Expression of exogenous polynucleotide sequences in a vertebrate
FR2645866B1 (fr) * 1989-04-17 1991-07-05 Centre Nat Rech Scient Nouvelles lipopolyamines, leur preparation et leur emploi
US5538722A (en) 1989-06-13 1996-07-23 Stanford University Isolation, growth, differentiation and genetic engineering of human muscle cells
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
IL103059A0 (en) 1991-09-30 1993-02-21 Boehringer Ingelheim Int Conjugates for introducing nucleic acid into higher eucaryotic cells
DE4139001A1 (de) * 1991-11-27 1993-06-03 Boehringer Mannheim Gmbh Verfahren zur einschleusung von nukleinsaeuren in zellen
US5972600A (en) 1992-04-03 1999-10-26 The Regents Of The University Of California Separation of active complexes
US5334761A (en) * 1992-08-28 1994-08-02 Life Technologies, Inc. Cationic lipids
GB9218762D0 (en) 1992-09-04 1992-10-21 Exxon Chemical Patents Inc Esters
HUT73383A (en) 1993-03-19 1996-07-29 Boehringer Sohn Ingelheim Process for preparing cancer vaccines
US5777153A (en) 1994-07-08 1998-07-07 Gilead Sciences, Inc. Cationic lipids
US5939401A (en) 1994-12-09 1999-08-17 Genzyme Corporation Cationic amphiphile compositions for intracellular delivery of therapeutic molecules
US5650096A (en) * 1994-12-09 1997-07-22 Genzyme Corporation Cationic amphiphiles for intracellular delivery of therapeutic molecules
US6071890A (en) 1994-12-09 2000-06-06 Genzyme Corporation Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
WO1996040726A1 (en) 1995-06-07 1996-12-19 Genta Incorporated Novel carbamate-based cationic lipids
AU707734B2 (en) 1995-06-07 1999-07-15 Regents Of The University Of California, The Stabilization of polynucleotide complexes
US5811406A (en) 1995-06-07 1998-09-22 Regents Of The University Of California Dry powder formulations of polynucleotide complexes
EP0840744A4 (en) 1995-06-07 1999-03-10 Genta Inc CATIONIC LIPIDS BASED ON PHOSPHONIC ACID
DE19521412A1 (de) * 1995-06-14 1996-12-19 Boehringer Mannheim Gmbh Neue kationische und polykationische Amphiphile, diese enthaltende Reagenzien und deren Verwendung
US6020526A (en) * 1995-07-21 2000-02-01 Genta, Incorporated Amide-based cationic lipids
DE19607686A1 (de) 1996-02-29 1997-09-04 Chemicon Lab Gmbh Neue metabolisierbare Lipopolyamine, deren Darstellung und Anwendung
US5747509A (en) 1996-06-03 1998-05-05 Schering Aktiengesellschaft Method for lowering plasma levels of lipoprotein(a)

Similar Documents

Publication Publication Date Title
Dauty et al. Dimerizable cationic detergents with a low cmc condense plasmid DNA into nanometric particles and transfect cells in culture
JP2001515060A5 (https=)
CA2671461C (en) Vesicles of self-assembling block copolymers and methods for making and using the same
EP2567693B1 (en) Lipid encapsulated interfering RNA
US7422902B1 (en) Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
CA2222328C (en) Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
US5661025A (en) Self-assembling polynucleotide delivery system comprising dendrimer polycations
AU3366901A (en) Novel colloid synthetic vectors for gene therapy
US20120021044A1 (en) Novel Cationic Lipid, A Preparation Method of the Same and A Delivery System Comprising the Same
JP2007521247A (ja) 生体適合性−遺伝子送達剤としての新規カチオン性リポポリマー
JP2004000245A (ja) 自己構築ポリヌクレオチド送達システム
Belmont et al. Aminoglycoside‐derived cationic lipids as efficient vectors for gene transfection in vitro and in vivo
AU6649496A (en) Novel amide-based cationic lipids
WO1991017424A1 (en) Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
Mével et al. Paromomycin and neomycin B derived cationic lipids: synthesis and transfection studies
US5980935A (en) Cationic lipids and methods of use therefor
JP4504559B2 (ja) 新リポポリアミン、その調製および適用
US20050100527A1 (en) Compounds for delivering substances into cells
JP4008491B2 (ja) カチオン輸送試薬
EP2802556B1 (en) Lipopolyamines of spermine type for construction of liposomal transfection systems
CN118201639A (zh) 肽-脂质缀合物
JP2004515228A (ja) 細胞への導入を容易にするジェミニ型のペプチド系界面活性化合物
Herringson et al. Targeting of plasmid DNA‐lipoplexes to cells with molecules anchored via a metal chelator lipid
KR20030040441A (ko) 산 민감성 화합물, 이의 제조방법 및 용도
US7005300B1 (en) Polyhydroxy diamine surfactants and their use in gene transfer